It is a pharma public limited company based in New Delhi, Delhi, India, established in 2005.
2005 | New Delhi, Delhi, India | AmalgamatedMks Pharma Limited, a amalgamated public limited company, was established on 01 August 2005 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232DL2005PLC139202. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.00 Cr.
Employing 1 professional, Its leadership includes Meenakshi Gupta (Director), Sanjay Gupta (Whole-Time Director), Sunil Gupta (Director). Past directors included Meenakshi Gupta, Sanjay Gupta, Kishori Lal Gupta. It holds no open charges and ₹0.90 M settled loans. Its latest AGM occurred on 28 September 2017, with the balance sheet filed on 31 March 2017. It is based at 302, Narmada Block-5 Pocket D-6, Vasant Kunj, New Delhi, Delhi, 110070.
U24232DL2005PLC139202
139202
01 August 2005
₹2.00 Cr
₹1.00 Cr
Roc Delhi
Unlisted
Amalgamated
Explore comprehensive insights into Mks Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meenakshi Gupta | Director | 17 Aug 2015 | Current |
| Sanjay Gupta | Whole-Time Director | 01 Aug 2005 | Current |
| Sunil Gupta | Director | 20 Mar 2015 | Current |
| Ravi Shankar Garg | Director | 15 May 2013 | Current |
| Rajat Gupta | Director | 20 May 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 01 Sep 2006 | Past |
| Pramod Abcsdd | Director | 30 Aug 2016 | Past |
| Pramod Abcsdd | Director | 17 Aug 2015 | Past |
| Pramod Abcsdd | Director | 20 May 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mks Pharma Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 82.83% decrease. The company also saw a substantial fall in profitability, with a 93.43% decrease in profit. The company's net worth moved up by a moderate rise of 0.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Mks Pharma had a promoter holding of 98.97% and a public holding of 1.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹900,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jul 2006 | Oriental Bank Of Commerce | ₹0.60 M | Satisfied |
| 28 Mar 2006 | Oriental Bank Of Commerce | ₹0.30 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Mks Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mks Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mks Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Mks Pharma Limited last Annual general meeting of members was held on 28 Sep 2017 as per latest MCA records. was completed.
The activity Mks Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Delhi. was completed.
Rajat Gupta was appointed as a Director was appointed as a Director on 20 May 2016 & has been associated with this company since 9 years 6 months . was recorded as a recent event.
Progress on Meenakshi Gupta was appointed as a Director was appointed as a Director on 17 Aug 2015 & has been associated with this company since 10 years 3 months . was documented.
Sunil Gupta was appointed as a Director was appointed as a Director on 20 Mar 2015 & has been associated with this company since 10 years 8 months . was recorded as a recent event.
Progress on Ravi Shankar Garg was appointed as a Director was appointed as a Director on 15 May 2013 & has been associated with this company since 12 years 6 months . was documented.
The CIN of Mks Pharma Limited is U24232DL2005PLC139202.
Mks Pharma Limited is headquartered at 302, Narmada Block-5 Pocket D-6, Vasant Kunj, New Delhi, Delhi, 110070.
Mks Pharma Limited was incorporated on 01 August 2005.
The current directors of Mks Pharma Limited are
The primary industry of Mks Pharma Limited is Trade.
Mks Pharma Limited is unlisted.
The authorized capital of Mks Pharma Limited is ₹2.00 Cr, and the paid-up capital is ₹1.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX